This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Page and Henry¹ reported a close relationship between the consumption of nonsteroidal anti-inflammatory drugs (NSAIDs) and a significant increase in hospital admissions due to worsening of chronic heart failure (CHF). This is indeed an interesting observation, particularly if one considers the possible underlying mechanisms. Conventional NSAIDs have been associated with inflammation of the small intestine, apart from aspirin and nabumetone, which seem to spare the small bowel.² They may also contribute to increased intestinal permeability; interact with diuretics and angiotensin-converting enzyme inhibitors; and cause short-term hemodynamic effects, derangements of cellular integrity, and a reduction of the enterocyte barrier function due to chronic intestinal inflammation. Additionally, there may be abnormal bowel wall function in CHF due to venous congestion and a low cardiac output. As a plausible consequence, bacterial translocation may occur (ie, the translocation of bacteria and bacterial products such as lipopolysaccharide [endotoxin]), a phenomenon that has been proposed as . . . [Full Text of this Article]

RELATED ARTICLE

Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients: An Underrecognized Public Health Problem
John Page and David Henry
Arch Intern Med. 2000;160(6):777-784.
ABSTRACT | FULL TEXT